Table 1.
Demographics of the 574 cases diagnosed by the diagnostic lab until 31st March, separated by community-onset, indeterminate, probable nosocomial, and definite nosocomial infections
| Overall | Community | Indeterminate | Probable nosocomial | Definite nosocomial | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Cases (n) | 574 | 471 | 82% | 17 | 3% | 27 | 5% | 59 | 10% | |
| In-hospital mortality | 114 | 20% | 81 | 17% | 4 | 24% | 6 | 22% | 23 | 39% |
| Inpatients | 483 | 84% | 380 | 81% | — | — | — | |||
| Length of stay (IQR) | 12 (5–27) | 9 (4–16) | 19 (11–24) | 23 (21–30) | 53 (36–94) | |||||
| Sex | ||||||||||
| Female | 251 | 44% | 208 | 44% | 4 | 24% | 9 | 33% | 30 | 51% |
| Male | 323 | 56% | 263 | 56% | 13 | 76% | 18 | 67% | 29 | 49% |
| Median age (IQR) | 61 (48–76) | 58 (45–73) | 73 (61–80) | 75 (69–81) | 73 (61–82) | |||||
| Ethnicity | ||||||||||
| Known | 455 | 79% | 377 | 80% | 10 | 59% | 18 | 67% | 50 | 85% |
| White | 230 | 51% | 174 | 46% | 5 | 50% | 14 | 78% | 37 | 74% |
| BAME | 225 | 49% | 203 | 54% | 5 | 50% | 4 | 22% | 13 | 26% |
| Pregnant | 13 | 2% | 13 | 3% | 0 | 0% | 0 | 0% | 0 | 0% |
| Charlson score (IQR) | 2 (1–5) | 1 (0–3) | 5 (4–6) | 5 (4–6) | 5 (4–6) | |||||
| Hypertension | 257 | 45% | 203 | 43% | 7 | 41% | 17 | 63% | 30 | 51% |
| Congestive cardiac failure | 28 | 5% | 13 | 3% | 1 | 6% | 4 | 15% | 10 | 17% |
| Myocardial infarction | 19 | 3% | 12 | 3% | 1 | 6% | 2 | 7% | 4 | 7% |
| Diabetes mellitus | 168 | 29% | 138 | 29% | 3 | 18% | 9 | 33% | 18 | 31% |
| End organ damage | 38 | 7% | 28 | 6% | 3 | 18% | 3 | 11% | 4 | 7% |
| Renal impairment | 111 | 19% | 87 | 18% | 4 | 24% | 6 | 22% | 14 | 24% |
| Mild | 49 | 9% | 34 | 7% | 3 | 18% | 3 | 11% | 9 | 15% |
| Moderate | 7 | 1% | 5 | 1% | 0 | 0% | 1 | 4% | 1 | 2% |
| Severe | 54 | 9% | 47 | 10% | 1 | 6% | 2 | 7% | 4 | 7% |
| Dementia | 50 | 9% | 31 | 7% | 2 | 12% | 4 | 15% | 13 | 22% |
| COPD | 46 | 8% | 30 | 6% | 3 | 18% | 3 | 11% | 10 | 17% |
| Immunosuppression | 35 | 6% | 24 | 5% | 0 | 0% | 3 | 11% | 8 | 14% |
| HIV/AIDS | 2 | 0% | 2 | 0% | 0 | 0% | 0 | 0% | 0 | 0% |
| Solid tumour | 71 | 13% | 45 | 10% | 6 | 35$ | 6 | 22% | 14 | 24% |
| Localized | 53 | 9% | 36 | 8% | 3 | 18% | 4 | 15% | 10 | 17% |
| Metastatic | 18 | 3% | 9 | 2% | 3 | 18% | 2 | 7% | 4 | 7% |
| Haematological malignancy | 14 | 2% | 4 | 1% | 2 | 12% | 2 | 7% | 6 | 10% |
| Lymphoma | 7 | 1% | 1 | 0% | 2 | 12% | 1 | 4% | 3 | 5% |
| Leukaemia | 7 | 1% | 3 | 1% | 0 | 0% | 1 | 4% | 3 | 5% |
IQR, interquartile range; COPD, chronic obstructive pulmonary disease.